These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9655259)

  • 1. Effect of postnecrotic and alcoholic hepatic cirrhosis on development of benign prostatic hyperplasia.
    Cetinkaya M; Cetinkaya H; Ulusoy E; Baz S; Memiş A; Yaşa H; Yanik B; Oztürk B; Uzunalimoğlu O
    Prostate; 1998 Jul; 36(2):80-4. PubMed ID: 9655259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
    Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
    J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between liver cirrhosis and benign prostatic hyperplasia: a morphological study.
    Frea B; Annoscia S; Stanta G; Lozzi C; Carmignani G
    Urol Res; 1987; 15(5):311-4. PubMed ID: 2446412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine environment of benign prostatic hyperplasia: prostate size and volume are correlated with serum estrogen concentration.
    Suzuki K; Ito K; Ichinose Y; Kurokawa K; Suzuki T; Imai K; Yamanaka H; Honma S
    Scand J Urol Nephrol; 1995 Mar; 29(1):65-8. PubMed ID: 7542400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40-79 years.
    Liao CH; Li HY; Chung SD; Chiang HS; Yu HJ
    Aging Male; 2012 Mar; 15(1):28-33. PubMed ID: 21247242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are total prostate-specific antigen serum levels in cirrhotic men different from those in normal men?
    Vicentini FC; Botelho LA; Hisano M; Ebaid GX; Lucon M; Lucon AM; Srougi M
    Urology; 2009 May; 73(5):1032-5. PubMed ID: 19286245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of sex steroid hormones in benign prostatic hyperplasia.
    Asiedu B; Anang Y; Nyarko A; Doku DA; Amoah BY; Santa S; Ngala RA; Asare GA
    Aging Male; 2017 Mar; 20(1):17-22. PubMed ID: 28084142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sex hormones and measures of benign prostatic hyperplasia.
    Roberts RO; Jacobson DJ; Rhodes T; Klee GG; Leiber MM; Jacobsen SJ
    Prostate; 2004 Oct; 61(2):124-31. PubMed ID: 15305335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response of prostate specific antigen to testosterone surge after luteinizing hormone-releasing hormone analogue in prostate cancer and benign prostatic hyperplasia.
    Agarwal DK; Costello AJ; Peters J; Sikaris K; Crowe H
    BJU Int; 2000 Apr; 85(6):690-5. PubMed ID: 10759667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endocrine environment of benign prostatic hyperplasia--relationships of sex steroid hormone levels with age and the size of the prostate].
    Suzuki K; Inaba S; Takeuchi H; Takezawa Y; Fukabori Y; Suzuki T; Imai K; Yamanaka H; Honma S
    Nihon Hinyokika Gakkai Zasshi; 1992 May; 83(5):664-71. PubMed ID: 1379658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.
    Porcaro AB; Ghimenton C; Petrozziello A; Sava T; Migliorini F; Romano M; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C
    Anticancer Res; 2012 Oct; 32(10):4523-32. PubMed ID: 23060581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy.
    Porcaro AB; Caruso B; Terrin A; De Luyk N; Cacciamani G; Corsi P; Inverardi D; De Marchi D; Baldassarre R; Cerruto M; Ghimenton C; Brunelli M; Zecchini Antoniolli S; Petrozziello A; Artibani W
    Arch Ital Urol Androl; 2016 Mar; 88(1):17-22. PubMed ID: 27072171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms.
    Vesely S; Knutson T; Damber JE; Dicuio M; Dahlstrand C
    Scand J Urol Nephrol; 2003; 37(4):322-8. PubMed ID: 12944191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men.
    Wang YJ; Wu JC; Lee SD; Tsai YT; Lo KJ
    Hepatogastroenterology; 1991 Dec; 38(6):531-4. PubMed ID: 1778585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity may influence the relationship between sex hormones and lower urinary tract symptoms.
    Antunes AA; Araújo LH; Nakano E; Muracca E; Srougi M
    Int Braz J Urol; 2014; 40(2):240-6. PubMed ID: 24856492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology.
    Schatzl G; Brössner C; Schmid S; Kugler W; Roehrich M; Treu T; Szalay A; Djavan B; Schmidbauer CP; Söregi S; Madersbacher S
    Urology; 2000 Mar; 55(3):397-402. PubMed ID: 10699620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL.
    Miyoshi Y; Uemura H; Suzuki K; Shibata Y; Honma S; Harada M; Kubota Y
    Andrology; 2017 Mar; 5(2):262-267. PubMed ID: 27813361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of vitamin D receptor and 17 hydroxylase gene polymorphisms with benign prostatic hyperplasia and benign prostatic enlargement.
    Schatzl G; Gsur A; Bernhofer G; Haidinger G; Hinteregger S; Vutuc C; Haitel A; Micksche M; Marberger M; Madersbacher S
    Urology; 2001 Mar; 57(3):567-72. PubMed ID: 11248649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
    Lee JH; Kim Y; Park YW; Lee DG
    J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.
    Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ
    Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.